Quick Answer
Silexion Therapeutics Corp reported Shares Outstanding of 3.13 billion shares for fiscal year 2025.
Silexion Therapeutics Corp Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 3.13B | +2436.0% |
| 2024 | 123.29M | +26.9% |
| 2023 | 97.12M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 3.13M | -72.0% | +439.5% |
| June 30, 2025 | 579,536 | +164.2% | -93.3% |
| March 31, 2025 | 8.69M | — | +6950.0% |
| December 31, 2024 | 123,290 | -85.9% | -98.9% |
| September 30, 2024 | 11.18M | — | +4996.8% |
| June 30, 2024 | 219,354 | — | -74.9% |
| December 31, 2023 | 873,665 | — | — |
- Silexion Therapeutics Corp showed an increase of +2436.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, Silexion Therapeutics Corp’s shares outstanding has grown by 3119.4% (from 97.12 million shares to 3.13 billion shares).
- The most recent figure is from Silexion Therapeutics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: